Winslow Capital Management’s AbbVie ABBV Stock Holding History

Winslow Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,375,770	Closed	-$268M	–	69
2021 Q2	$268M	Buy	+2,375,770	New	+$268M	1.04%	44
2019 Q1	–	Sell	-5	Closed	–	–	62
2018 Q4	$0	Hold	5	–	–	﹤0.01%	95
2018 Q3	$0	Hold	5	–	–	﹤0.01%	93
2018 Q2	$0	Hold	5	–	–	﹤0.01%	90
2018 Q1	$0	Sell	5 -1	-17%	-$110	﹤0.01%	90
2017 Q4	$1K	Hold	6	–	–	﹤0.01%	93
2017 Q3	$1K	Hold	6	–	–	﹤0.01%	88
2017 Q2	$0	Hold	6	–	–	﹤0.01%	93
2017 Q1	$0	Sell	6 -20	-77%	-$1.26K	﹤0.01%	89
2016 Q4	$2K	Sell	26 -29	-53%	-$1.77K	﹤0.01%	84
2016 Q3	$3K	Buy	55 +54	+5,400%	+$3.5K	﹤0.01%	154
2016 Q2	$0	Sell	1 -1,915,250	-100%	-$117M	﹤0.01%	137
2016 Q1	$109M	Buy	1,915,251 +1,915,135	+1,650,978%	+$107M	0.43%	61
2015 Q4	$7K	Buy	+116	New	+$6.68K	﹤0.01%	69
2015 Q1	–	Sell	-5,771,415	Closed	-$378M	–	66
2014 Q4	$378M	Sell	5,771,415 -5,220,827	-47%	-$329M	1.17%	42
2014 Q3	$635M	Buy	10,992,242 +4,712,936	+75%	+$262M	1.94%	16
2014 Q2	$354M	Buy	+6,279,306	New	+$329M	1.08%	44

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Winslow Capital Management's ABBV Position: Q3 2021 in Review

Winslow Capital Management sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 2,375,770 shares — an estimated $268M sold.

Winslow Capital Management first reported a position in ABBV in Q2 2014 and held it in 17 quarters. The position peaked at $635M in Q3 2014. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Winslow Capital Management reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
Winslow Capital Management sold 2,375,770 AbbVie shares in Q3 2021, an estimated $268M.
Winslow Capital Management first reported a position in AbbVie in Q2 2014 and held it in 17 quarters.
Winslow Capital Management's AbbVie position peaked at $635M in Q3 2014.
2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Winslow Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.